Cleared Traditional

K993280 - PROSTEC 125I BRACHYTHERAPY SEEDS

K993280 is an FDA 510(k) clearance for PROSTEC 125I BRACHYTHERAPY SEEDS, manufactured by Prostec, LLC. The device is a Class 2 Radiology device with product code KXK cleared through the Traditional 510(k) pathway after a 166-day FDA review.

K993280 · Prostec, LLC · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2000
Decision
166d
Days
Class 2
Risk

K993280 is an FDA 510(k) clearance for the PROSTEC 125I BRACHYTHERAPY SEEDS. Classified as Source, Brachytherapy, Radionuclide (product code KXK), Class II - Special Controls.

Submitted by Prostec, LLC (Miami, US). The FDA issued a Cleared decision on March 14, 2000 after a review of 166 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5730 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Prostec, LLC devices

FDA 510(k) Submission Details - K993280

510(k) Number K993280 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 30, 1999
Decision Date March 14, 2000
Days to Decision 166 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
59d slower than avg
Panel avg: 107d · This submission: 166d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

KXK Device Classification - Class 2, Special Controls

Product Code KXK Source, Brachytherapy, Radionuclide
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5730
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - KXK Source, Brachytherapy, Radionuclide

All 79
Devices cleared under the same product code (KXK) and FDA review panel - the closest regulatory comparables to K993280.
ISOSEED PD-103
K993552 · Bebig Isotopentechnik GmbH · Mar 2000
I-PLANT, MODEL 3500
K994317 · Implant Sciences Corp. · Mar 2000
125-IMPLANT SEEDS, MODEL STM1250
K991881 · Sourcetech Medical, LLC · Mar 2000
10 CURIE IRDIUM 192, CSN00100-192
K991571 · Alpha-Omega Services, Inc. · Feb 2000
PHARMASEED, MODEL BT-103-1
K992007 · Syncor Pharmaceuticals, Inc. · Jan 2000
PHARMASEED, MODEL BT-125-1
K992008 · Syncor Pharmaceuticals, Inc. · Dec 1999